BMC pulmonary medicine
Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study.
Timothy Ho Him Kam, Kevin Ka Ho Kam, Michael Ka Lam Wong, Bryan Ping Yen Yan, Guangming Tan
Published: 202610.1186/s12890-025-04069-y
Abstract
BACKGROUND: For patients with chronic thromboembolic pulmonary hypertension (CTEPH), balloon pulmonary angioplasty (BPA) has been associated with superior reductions in mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) whe…
Preview only. Read the full abstract at the source